Latest Form 4 insider transactions

Tim Truels Hansen, Chief Commercial Officer of Dorian Lpg Ltd., sold 25,000 shares of common stock on August 11, 2026 for $45.04 per share.

Symeon Pariaros, Chief Administrative Officer of EuroDry Ltd., sold 1,900 shares of common stock on August 12, 2026 for $39.98 per share.

Rocket Lab Corporation announces the lapse of the HSR waiting period, filing of Form S-4, and FCC applications, marking substantial progress in its proposed acquisition of Iridium Communications Inc.

Rocket Lab Corporation announces the lapse of the HSR waiting period, filing of Form S-4, and FCC applications, marking substantial progress in its proposed acquisition of Iridium Communications Inc.

Chicago Atlantic BDC announced its second quarter 2026 financial results, reporting $14.0 million in total investment income and progress on its merger with REFI.

Mark Okey Decker Jr, CEO and President and a Director of Global Medical REIT Inc., purchased 550 shares of common stock on August 11, 2026 for $36.00 per share.

Charles Fitzgerald, a Director of Global Medical REIT Inc., purchased 14,000 shares of common stock on August 11, 2026 for $35.78 per share.

Leon Recanati, a Director of Evogene Ltd., purchased 460,000 shares of common stock on August 11, 2026 for $0.64 per share.

Jack Jiajia Huang, Chief Executive Officer, a Director and 10% owner of 51Talk Online Education Group, purchased 592,320 shares of common stock on August 11, 2026.

Michael G Potter, Chief Financial Officer of Bitdeer Technologies Group, purchased 25,000 shares of common stock on August 12, 2026 for $9.04 per share.

Yu Dunde, Chief Executive Officer and a Director of Tuniu Corp, reported multiple transactions in common stock on August 13, 2026.

Bin Mo, Vice President, Finance of NetEase, Inc., received 716 shares of common stock on August 11, 2026.

Rocket Lab Corporation has filed an 8-K report detailing the pro forma financial information related to its pending merger with Iridium Communications Inc., including financial statements and exhibits.

Jeff Kuai, General Manager, Pizza Hut of Yum China Holdings, Inc., sold 14,586 shares of common stock on August 12, 2026.

Yanjun Wang, CCO and GC of Sea Ltd, sold 3,000 shares of common stock on August 11, 2026.

Xiaodong Li, Chairman and CEO and a Director of Sea Ltd, sold 1,057,650 shares of common stock on August 11, 2026.

Zhimin Feng, President of Sea Ltd, sold 30,000 shares of common stock on August 11, 2026.

Feng Zhao, President of Garena of Sea Ltd, sold 4,000 shares of common stock on August 11, 2026.

Tianyu Hou, CFO of Sea Ltd, sold 5,000 shares of common stock on August 11, 2026 for $128.28 per share.

ON Semiconductor Corporation announced the early termination of the HSR waiting period for its proposed merger with Synaptics Incorporated, clearing a significant regulatory milestone.

ON Semiconductor Corporation announced the early termination of the HSR waiting period for its proposed merger with Synaptics Incorporated, clearing a significant regulatory milestone.

American Water CEO John Griffith outlines the company's strategy to address massive underinvestment in the U.S. water sector through acquisitions and infrastructure upgrades, emphasizing scale and risk management.

American Water CEO John Griffith outlines the company's strategy to address massive underinvestment in the U.S. water sector through acquisitions and infrastructure upgrades, emphasizing scale and risk management.

Ximing Huang, CEO, President, a Director and 10% owner of Sharing Economy International Inc., received 1 shares of common stock on 2026-08-11-05:00.

SPACsphere Acquisition Corp. and Mobilewalla have filed a registration statement on Form S-4, a key step towards their previously announced business combination, which is expected to result in Mobilewalla becoming a publicly traded company.

Awny Samaan Botros Farajallah, Chief Medical Officer of Takeda Pharmaceutical Co Ltd, sold 14,006 shares of common stock on August 10, 2026 for $17.10 per share.

Ramy Riad Ahmed Ibrahim, President, PDT BU of Takeda Pharmaceutical Co Ltd, sold 7,277 shares of common stock on August 10, 2026 for $17.10 per share.

Rhonda Janice Pacheco, President, U.S. Business Unit of Takeda Pharmaceutical Co Ltd, sold 16,901 shares of common stock on August 10, 2026 for $17.10 per share.

Lauren Rusckowski Duprey, Chief Transformation Officer of Takeda Pharmaceutical Co Ltd, sold 47,586 shares of common stock on August 10, 2026 for $17.10 per share.

Andrew Stewart Plump, President, R&D and a Director of Takeda Pharmaceutical Co Ltd, sold 165,393 shares of common stock on August 10, 2026 for $17.10 per share.